Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Erhardt

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1993
Validation of primary and secondary outcomes and classification of mode of death among patients with clinical evidence of heart failure after a myocardial infarction: a report from the Acute Infarction Ramipril Efficacy (AIRE) Study InvestigatorsJ G Cleland, L Erhardt, A S Hall, et al.
Acta Medica Scandinavica|January 1, 1983
Comparative study of tocainide and lidocaine in patients admitted for suspected acute myocardial infarctionN Rehnqvist, L Erhardt, C G Ericsson, et al.
Lancet (London, England)|October 1, 1994
Myocardial infarction associated with homozygous resistance to activated protein CJ Holm, B Zöller, P J Svensson, et al.
European Heart Journal|January 1, 1997
Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study InvestigatorsJ G Cleland, L Erhardt, G Murray, et al.
American Heart Journal|May 1, 1986
Repeated exercise and redistribution thallium-201 scintigrams in patients with myocardial infarction treated with timolol or placeboC G Ericsson, A Hamsten, A Granath, et al.
Clinical Physiology (Oxford, England)|November 1, 1992
Myocardial reperfusion in thrombolysis A 99Tcm-Sestamibi SPECT study in patients with acute myocardial infarctionP A Boström, H Diemer, M Freitag, et al.
International Journal of Cardiology|January 11, 2001
Effects on quality of life, symptoms and daily activity 6 months after termination of an exercise training programme in heart failure patientsR Willenheimer, E Rydberg, C Cline, et al.
Journal of Internal Medicine|January 20, 2005
Factors associated with development of stroke long-term after myocardial infarction: experiences from the LoWASA trialJ Herlitz, J Holm, M Peterson, et al.
Lakartidningen|December 4, 2001
[Quality assurance of secondary prevention of coronary artery disease. Ongoing project offers possibilities for improved treatment]H Brandström, L Erhardt, B Hedbäck, et al.
Journal of Internal Medicine|January 1, 1996
Continuous vectorcardiographic changes in relation to scintigraphic signs of reperfusion in patients with acute myocardial infarction receiving thrombolytic therapyP Juhlin, P A Boström, O Hansen, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Journal of Cardiovascular Pharmacology|January 1, 1993
Validation of primary and secondary outcomes and classification of mode of death among patients with clinical evidence of heart failure after a myocardial infarction: a report from the Acute Infarction Ramipril Efficacy (AIRE) Study InvestigatorsJ G Cleland, L Erhardt, A S Hall, et al.
Acta Medica Scandinavica|January 1, 1983
Comparative study of tocainide and lidocaine in patients admitted for suspected acute myocardial infarctionN Rehnqvist, L Erhardt, C G Ericsson, et al.
Lancet (London, England)|October 1, 1994
Myocardial infarction associated with homozygous resistance to activated protein CJ Holm, B Zöller, P J Svensson, et al.
European Heart Journal|January 1, 1997
Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study InvestigatorsJ G Cleland, L Erhardt, G Murray, et al.
American Heart Journal|May 1, 1986
Repeated exercise and redistribution thallium-201 scintigrams in patients with myocardial infarction treated with timolol or placeboC G Ericsson, A Hamsten, A Granath, et al.
Clinical Physiology (Oxford, England)|November 1, 1992
Myocardial reperfusion in thrombolysis A 99Tcm-Sestamibi SPECT study in patients with acute myocardial infarctionP A Boström, H Diemer, M Freitag, et al.
International Journal of Cardiology|January 11, 2001
Effects on quality of life, symptoms and daily activity 6 months after termination of an exercise training programme in heart failure patientsR Willenheimer, E Rydberg, C Cline, et al.
Journal of Internal Medicine|January 20, 2005
Factors associated with development of stroke long-term after myocardial infarction: experiences from the LoWASA trialJ Herlitz, J Holm, M Peterson, et al.
Lakartidningen|December 4, 2001
[Quality assurance of secondary prevention of coronary artery disease. Ongoing project offers possibilities for improved treatment]H Brandström, L Erhardt, B Hedbäck, et al.
Journal of Internal Medicine|January 1, 1996
Continuous vectorcardiographic changes in relation to scintigraphic signs of reperfusion in patients with acute myocardial infarction receiving thrombolytic therapyP Juhlin, P A Boström, O Hansen, et al.
Pageof 11